TAL Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency BWA Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress PLMR Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Not Disclosed Teck Resources Q1 2026 Earnings Strong EPS Beat Amid Market Headwinds TVTX Q1 2026 Earnings EPS Misses Estimates as Clinical Costs Weigh on Results Stock Surges 78